AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2006
2004 | 2005 | 2006
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
A 12-WEEK OPEN LABEL STUDY OF HIGH DOSE QUETIAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
|
Original Research | ||
|
A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF OLANZAPINE IN ADOLESCENTS WITH SCHIZOPHRENIA
|
Encore Presentation | ||
|
A FIXED DOSE STUDY OF THE EFFICACY AND SAFETY OF DULOXETINE FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER
|
Encore Presentation | ||
|
A proton magnetic resonance spectroscopy study of the effects of lithium on myo-inositol in bipolar depressed adolescents
|
Original Research | ||
|
A Retrospective Chart Review of Topiramate-Induced Weight Loss in Patients with Psychotropic-Induced Weight Gain
|
Work in Progress | ||
|
A RETROSPECTIVE EVALUATION OF THE EFFECT OF RECENTLY-DIAGNOSED DEPRESSION ON GLYCEMIC CONTROL IN DIABETIC VA PATIENTS
|
Work in Progress | ||
|
Acetylcholinesterase Inhibitor-Induced Dystonia
|
Best Practices | ||
|
Actos Induced Aggression: A Case Report
|
Best Practices | ||
|
Adherence to Metabolic Monitoring and Assessment of Risk Factors for Diabetes Mellitus in Patients on Atypical Antipsychotics
|
Work in Progress | ||
|
ADVERSE OUTCOMES ASSOCIATED WITH THE USE OF ATYPICAL ANTIPSYCHOTICS FOR THE MANAGEMENT OF BEHAVIORAL AND PSYCHOLOGICAL SIGNS AND SYMPTOMS OF DEMENTIA
|
Work in Progress | ||
|
An Evaluation of Lamotrigine on Mood in Older Adults with Epilepsy and Comorbid Depressive Symptoms
|
Encore Presentation | ||
|
ANALYSIS OF VENLAFAXINE XR TREATMENT IN PREVENTING RECURRENCE IN PATIENTS WITH RECURRENT UNIPOLAR MAJOR DEPRESSION: A PLACEBO-CONTOLLED TRIAL
|
Encore Presentation | ||
|
Analysis to Correlate Serum Concentrations of Quetiapine and Risperidone with Efficacy, Side Effects and Tolerability
|
Work in Progress | ||
|
ANTIPSYCHOTIC ADHERENCE: AN ASSESSMENT OF PATIENT SELF-REPORT, ATTITUDES, INSIGHT AND ABILITY
|
Original Research | ||
|
Aripiprazole vs Olanzapine in Schizophrenia: A 52-Week, Open-Label Study
|
Encore Presentation | ||
|
ASSESSING RESILIENCE AS A PREDICTOR OF REMISSION IN PTSD: AN ANALYSIS OF PATIENTS TREATED WITH VENLAFAXINE XR OR PLACEBO
|
Original Research | ||
|
Assessment of Infection Risk during Clozapine Treatment in an Iowa Medicaid Population
|
Work in Progress | ||
|
Assessment of Pharmacists' Perceptions of Psychiatric Medications and Illnesses
|
Encore Presentation | ||
|
ASSESSMENT OF VITAL SIGNS IN CHILDREN AND ADOLESCENTS TREATED WITH ADHD MEDICATIONS
|
Work in Progress | ||
|
ASSOCIATION BETWEEN MEDICATION CHANGES AND FALLS IN GERIATRIC PSYCHIATRY PATIENTS
|
Encore Presentation | ||
|
ATOMOXETINE IN ADOLESCENTS WITH ADHD AND COMORBID DEPRESSION
|
Encore Presentation | ||
|
ATOMOXETINE TREATMENT FOR PEDIATRIC PATIENTS WITH ADHD AND COMORBID ANXIETY
|
Encore Presentation | ||
|
Bipolar Disorder: Relationship Between Body Mass Index and Quality of Life
|
Encore Presentation | ||
|
Comparison of Olanzapine, Quetiapine, and Risperidone in First-Episode Psychosis: A Randomized, 52-Week Trial
|
Encore Presentation | ||
|
Depression as a risk factor for worsening platelet aggregation in stage five chronic kidney disease (CKD) patients receiving hemodialysis
|
Work in Progress | ||
|
Determining the mechanism of a drug-drug interaction: Venlafaxine and P-glycoprotein
|
Original Research | ||
|
DEVELOPMENT OF AN INTERDICISPLINARY TREATMENT REFRACTORY DEPRESSION CLINIC
|
Best Practices | ||
|
Donepezil to galantamine conversion: rapid titration tolerability.
|
Original Research | ||
|
DOSING AND SWITCHING PATTERNS OF MIGRAINE PREVENTION THERAPY IN THE MANAGED CARE SETTING
|
Original Research | ||
|
DULOXETINE AS AN EFFECTIVE TREATMENT FOR IMPROVING PAINFUL PHYSICAL SYMPTOMS AND FUNCTIONING ASSOCIATED WITH GENERALIZED ANXIETY DISORDER
|
Encore Presentation | ||
|
DULOXETINE IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN: RESPONSE PROFILE
|
Encore Presentation | ||
|
DULOXETINE: META-ANALYSES OF SUICIDAL BEHAVIORS AND THOUGHTS IN CLINICAL TRIALS FOR MAJOR DEPRESSIVE DISORDER
|
Encore Presentation | ||
|
Effect of Bupropion on Physiological Measures of Stress in Smokers During Nicotine Withdrawal
|
Encore Presentation | ||
|
Efficacy of Quetiapine Monotherapy in Bipolar Depression: A Confirmatory Double-Blind, Placebo-Controlled Study (The BOLDER II Study)
|
Original Research | ||
|
Estimating Risk Factors for Diabetes Among Schizophrenics with Exposure to Atypical Antipsychotics.
|
Original Research | ||
|
EVALUATING PREDICTORS BASED ON A POOLED ANALYSIS OF VENLAFAXINE XR IN THE SHORT-TERM TREATMENT OF PANIC DISORDER
|
Original Research | ||
|
EVALUATION OF DIVALPROEX SODIUM DELAYED-RELEASE DOSING IN ADULT, CHILD, AND ADOLESCENT INPATIENTS ADMITTED TO A PSYCHIATRIC UNIT AT A UNIVERSITY MEDICAL CENTER
|
Work in Progress | ||
|
Evaluation of Long-Acting Injectable Risperidone for Older Adult Inpatients with Psychosis
|
Encore Presentation | ||
|
EVALUATION OF PATIENT RISKS ASSOCIATED WITH CONCURRENT USE OF LINEZOLID WITH SEROTONIN REUPTAKE INHIBITORS
|
Work in Progress | ||
|
EVALUATION OF THE TIMELINE TO MAINTENANCE ANTIPSYCHOTIC THERAPY IN AN INPATIENT PSYCHIATRIC HOSPITAL
|
Work in Progress | ||
|
EVALUATION OF THE USE OF LOW DOSE ANTIPSYCHOTICS IN THE TREATMENT OF NONPSYCHOTIC POSTTRAUMATIC STRESS DISORDER
|
Work in Progress | ||
|
EVALUATION OF UTILIZATION AND DOCUMENTATION OF PRO RE NATA (PRN) PSYCHOTROPIC MEDICATIONS
|
Original Research | ||
|
Evaluation of Weight Gain and Extrapyramidal Symptoms in Forensic, Chronically Ill Psychiatric Patients
|
Encore Presentation | ||
|
High Risk - High Alert Medication Management in a State Psychiatric Facility
|
Best Practices | ||
|
Hyperlipidemia following Treatment with Second-Generation Antipsychotic Medications
|
Encore Presentation | ||
|
Impact of Community Pharmacist-Provided Medication Therapy Management on Outcomes in Opiate Dependence
|
Best Practices | ||
|
Improvement in the Quality of Life in People with Epilepsy and Comorbid Depressive Symptoms after Lamotrigine Adjunctive Therapy
|
Encore Presentation | ||
|
INFLUENCE OF MAJOR DEPRESSIVE DISORDER ON THE PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF METHADONE
|
Encore Presentation | ||
|
Intramuscular Aripiprazole in Acute Schizophrenia: A Pivotal Phase 3 Study
|
Encore Presentation | ||
|
Intramuscular Aripiprazole vs. Placebo for Agitation in Acute Mania
|
Encore Presentation | ||
|
Intraparenchymal hemorrhage associated with sildenafil
|
Encore Presentation | ||
|
Jimson weed induced acute psychosis in a 14-year-old patient
|
Best Practices | ||
|
LOW INCIDENCE OF COGNITIVE AND BEHAVIORAL ADVERSE EVENTS IN RASAGILINE-TREATED PATIENTS WITH EARLY TO ADVANCED PARKINSON’S DISEASE (PD)
|
Encore Presentation | ||
|
Maintenance of Response to Memantine Treatment in Moderate to Severe Alzheimer’s Disease Patients Receiving Stable Donepezil Treatment
|
Encore Presentation | ||
|
Medication reconciliation and discharge clinic on an inpatient psychiatric unit: A pilot study
|
Best Practices | ||
|
Medication Reconciliation Model in an Acute Care Psychiatric Facility
|
Best Practices | ||
|
Medication Utilization Patterns and Methods of Suicidality in Borderline Personality Disorder
|
Encore Presentation | ||
|
Metabolic Effects Associated with Atypical Antipsychotic Treatment in the Developmentally Disabled
|
Encore Presentation | ||
|
METABOLIC MONITORING INITIATIVE IN AN ACUTE CARE PSYCHIATRIC HOSPITAL SETTING
|
Best Practices | ||
|
Naltrexone's Effect on Weight Gain in Adolescent Patients Receiving Second Generation Antipsychotics
|
Work in Progress | ||
|
Neuroleptic Malignant Syndrome due to Long Acting Intramuscular Risperidone and Successful Rechallenge With an Extended Interval Dosing Regimen
|
Best Practices | ||
|
OFF-LABEL USE OF ATYPICAL ANTIPSYCHOTICS
|
Work in Progress | ||
|
OLANZAPINE IN THE TREATMENT OF ACUTE MANIC OR MIXED EPISODES IN ADOLESCENTS; A 3-WEEK RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
|
Encore Presentation | ||
|
OLANZAPINE/FLUOXETINE COMBINATION VERSUS LAMOTRIGINE IN THE LONG-TERM TREATMENT OF BIPOLAR I DEPRESSION
|
Encore Presentation | ||
|
ONSET OF ANTIDEPRESSANT ACTION AND ACUTE EFFICACY AND SAFETY OF DULOXETINE VERSUS ESCITALOPRAM AND PLACEBO IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
|
Encore Presentation | ||
|
PATTERNS OF TOPIRAMATE UTILIZATION AMONG COMMERCIALLY INSURED PATIENTS: DIAGNOSIS, COMORBIDITIES, AND REAL-WORLD DOSING
|
Original Research | ||
|
Patterns of topiramate utilization among Medicaid patients: diagnosis, comorbidities and real-world dosing
|
Original Research | ||
|
Pica Episodes Following Initiation of Bupropion in an Institutionalized Developmentally Disabled Adult
|
Best Practices | ||
|
Possible Intranasal Quetiapine Misuse: A Case Report
|
Best Practices | ||
|
Pre-screening of Metabolic Abnormalities among Patients with Serious Mental Illness and Concurrent Antipsychotic Therapy
|
Best Practices | ||
|
PREDICTING REMISSION IN DEPRESSED OUTPATIENTS TREATED WITH VENLAFAXINE EXTENDED RELEASE (XR) OR SELECTIVE SEROTONIN REUPTAKE INHIBITORS BASED ON SYMPTOM IMPROVEMENT PATTERNS
|
Encore Presentation | ||
|
Prevalence and Use of Second Generation Antipsychotics in Children Age 0-11 Enrolled in a Medicaid Behavioral Health Managed Care Plan
|
Original Research | ||
|
Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationships with the age of initiation of prescribed stimulants.
|
Original Research | ||
|
Psychiatric Comorbidity Does Not Predict Interferon Treatment
|
Original Research | ||
|
PSYCHIATRIC PHARMACIST INTERVENTION AND CONSULTATION IN A LIVER CLINIC
|
Best Practices | ||
|
RASAGILINE IS EFFECTIVE AS MONOTHERAPY IN PATIENTS WITH EARLY PARKINSON’S DISEASE (PD) AND AS ADJUNCTIVE THERAPY IN MODERATE TO ADVANCED PD.
|
Encore Presentation | ||
|
Real World Usage of Weight Gain Drugs in Patients on Second-Generation Antipsychotics
|
Encore Presentation | ||
|
Relapse rates in Schizophrenic Patients Receiving Aripiprazole in Comparison to Other Atypical Antipsychotics
|
Original Research | ||
|
Remission in Schizophrenia: The Relationship to Baseline Symptoms and Changes in Symptom Domains During a One-Year Study.
|
Original Research | ||
|
Risks for CHD (Coronary Heart Disease) in Newly Admitted Adult Psychiatry Inpatients
|
Original Research | ||
|
Risperidone monotherapy versus risperidone or haloperidol plus sertraline for major depression with psychosis: results of a pilot, double-blind, placebo-controlled trial
|
Original Research | ||
|
Safety and Tolerability of the Selegiline Transdermal System 20 mg for Treatment of Major Depression
|
Encore Presentation | ||
|
Safety Profile associated with the concomitant use of lorazepam injection with olanzapine, ziprasidone or haloperidol injection.
|
Original Research | ||
|
Selective Serotonin Reuptake Inhibitors and Risk of Gastrointestinal Bleeding
|
Work in Progress | ||
|
SEROTONIN TRANSPORTER GENE POYMORPHISM IN HCV PATIENTS: PRELIMINARY FINDINGS
|
Work in Progress | ||
|
SSRI-Induced Ecchymosis
|
Best Practices | ||
|
The Association of Selective Serotonin Reuptake Inhibitors (SSRIs) and Hospitalization Rates in Patients with Alcohol Abuse and Alcohol Dependence
|
Work in Progress | ||
|
THE DOPAMINE-2 RECEPTOR TAQAI POLYMORPHISM, PROLACTIN ELEVATION, AND BONE MINERAL DENSITY IN PERSONS WITH SCHIZOPHRENIA
|
Original Research | ||
|
THE EFFECT OF OLANZAPINE AND RISPERIDONE ON TRIGLYCERIDES AND CHOLESTEROL IN CHILDREN AND ADOLESCENTS
|
Work in Progress | ||
|
The Effects of Haloperidol on Triglyceride Levels in Men and Women
|
Work in Progress | ||
|
THE FIRST 21-MONTHS OF SAFETY EXPERIENCE WITH POST-MARKETING USE OF OLANZAPINE’S INTRAMUSCULAR FORMULATION
|
Original Research | ||
|
The Prevalence of Thyroid Dysfunction in the Severe and Persistently Mentally ill
|
Original Research | ||
|
TOPIRAMATE FOR MIGRAINE PREVENTION IN THE MANAGED CARE SETTING
|
Original Research | ||
|
TREATMENT DISCONTINUATION IN ANTIPSYCHOTIC TRIALS AND CHANGE IN SCHIZOPHRENIA SYMPTOMS
|
Original Research | ||
|
Urine drug screen false positive for phencyclidine from use of diazepam and/or promethazine
|
Encore Presentation | ||
|
USE OF A BIOMARKER OF NOREPINEPHRINE TRANSPORTER (NET) INHIBITION TO ASSESS ATOMOXETINE EFFECTS DURING CLINICALLY RECOMMENDED DOSING
|
Encore Presentation | ||
|
Utilizing Pharmacy Student Conducted Telephone Follow-Up to Assess Medication Adherence in Discharged Psychiatric Patients
|
Work in Progress | ||
|
Value of the Pharmacist Obtained Medication History on a Behavioral Health Unit
|
Best Practices | ||
|
Weight Changes Following Switch From Oral Antipsychotics to Risperidone Long Acting Injection: A Retrospective Chart Review
|
Encore Presentation | ||
|
YMRS Line Analysis of Aripiprazole in Acute Mania: Pooled Data
|
Encore Presentation |